Previous Study: TRIO031
Next Study: TRIO038

Studies & Results


A Trial to Assess the Safety, Pharmacodynamic Effects, Pharmacokinetics and Efficacy of the MNK Inhibitor Tomivosertib (eFT508) in Combination with Paclitaxel, Following a Run-in Period of Tomivosertib Monotherapy, in Patients with Advanced Breast Cancer.

View FDA Study

For information on any of TRIO's clinical trials, please contact Valérie Bee, Director Project Management at